Fig. 1From: Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case reportTimeline of clinical course. Visual representation of patient’s diagnosis and initiation of therapy, with insight into onset of dermatologic and pulmonary irAEs (representative images at time of diagnosis) and attempted therapies. Follow-up chest computed tomography findings are shown. Follow-up exam of skin showed nearly complete resolution of initial findings, but was not documented in photographBack to article page